论文部分内容阅读
本文将６６例以强迫症、恐怖症为主的神经症患者分为两组，单纯治疗组以经典森田疗法进行治疗［１］，综合治疗组以新森田疗法（森田疗法合并药物治疗）进行治疗［２］，并使用ＳＣＬ－９０、ＥＰＱ、ＭＭＰＩ等量表进行了测评。结果表明：单纯治疗组与综合治疗组的疗效差异无显著性；并提示凡ＳＣＬ－９０的偏执因子分＞２．５分、ＭＭＰＩ标准量表中的癔病量表原始分及因子量表中的神经质因子高Ｔ分者，均显示综合治疗方式用药的必要性［３］。
This article will be 66 cases of obsessive-compulsive disorder, phobia-based neurosis patients were divided into two groups, the treatment group was treated with classic Morita therapy [1], the comprehensive treatment group with the new Morita therapy (Morita therapy combined with drug treatment) for treatment [2], and using SCL-90, EPQ, MMPI and other scales were evaluated. The results showed that: the treatment group and the treatment group was no significant difference between the efficacy; and prompted where SCL-90 paranoid factor score> 2.5 points, MMPI standard scale in the rickets scale original score and factor scale Neurological factors, high T points, all show the need for comprehensive treatment of medication [3].